Literature DB >> 25717215

NEONATAL VISUAL INFORMATION PROCESSING IN COCAINE-EXPOSED AND NON-EXPOSED INFANTS.

Lynn T Singer1, Robert Arendt1, Joseph Fagan1, Sonia Minnes1, Ann Salvator1, Tina Bolek1, Michael Becker1.   

Abstract

This study investigated early neonatal visual preferences in 267 poly drug exposed neonates (131 cocaine-exposed and 136 non-cocaine exposed) whose drug exposure was documented through interviews and urine and meconium drug screens. Infants were given four visual recognition memory tasks comparing looking time to familiarized stimuli of lattices and rectangular shapes to novel stimuli of a schematic face and curved hourglass and bull's eye forms. Cocaine-exposed infants performed more poorly, after consideration of confounding factors, with a relationship of severity of cocaine exposure to lower novelty score found for both self-report and biologic measures of exposure, Findings support theories which link prenatal cocaine exposure to deficits in information processing entailing attentional and arousal organizational systems. Neonatal visual discrimination and attention tasks should be further explored as potentially sensitive behavioral indicators of teratologic effects.

Entities:  

Keywords:  alcohol poly drug exposure; cocaine; information processing; marijuana; neonatal visual attention; visual recognition memory

Year:  1999        PMID: 25717215      PMCID: PMC4337949          DOI: 10.1016/S0163-6383(99)80002-2

Source DB:  PubMed          Journal:  Infant Behav Dev        ISSN: 0163-6383


  45 in total

1.  Perinatal cocaine effects on neonatal stress behavior and performance on the Brazelton Scale.

Authors:  L N Eisen; T M Field; E S Bandstra; J P Roberts; C Morrow; S K Larson; B M Steele
Journal:  Pediatrics       Date:  1991-09       Impact factor: 7.124

2.  The developmental implications of prenatal and/or postnatal crack cocaine exposure in preschool children: a preliminary report.

Authors:  S L Bender; C O Word; R J DiClemente; M R Crittenden; N A Persaud; L E Ponton
Journal:  J Dev Behav Pediatr       Date:  1995-12       Impact factor: 2.225

3.  Prenatal and intrapartum high-risk screening. I. Prediction of the high-rish neonate.

Authors:  C J Hobel; M A Hyvarinen; D M Okada; W Oh
Journal:  Am J Obstet Gynecol       Date:  1973-09-01       Impact factor: 8.661

4.  Cognitive development in the failure-to-thrive infant: a three-year longitudinal study.

Authors:  L T Singer; J F Fagan
Journal:  J Pediatr Psychol       Date:  1984-09

5.  Recognition memory in Down's syndrome and normal infants.

Authors:  S B Miranda; R L Fantz
Journal:  Child Dev       Date:  1974-09

6.  Elevated plasma norepinephrine after in utero exposure to cocaine and marijuana.

Authors:  M Mirochnick; J Meyer; D A Frank; H Cabral; E Z Tronick; B Zuckerman
Journal:  Pediatrics       Date:  1997-04       Impact factor: 7.124

7.  Effects of in utero substance exposure on infant neurobehavior.

Authors:  B Napiorkowski; B M Lester; M C Freier; S Brunner; L Dietz; A Nadra; W Oh
Journal:  Pediatrics       Date:  1996-07       Impact factor: 7.124

8.  Age differences in infants' attention to patterns of different complexities.

Authors:  W M Brennan; E W Ames; R W Moore
Journal:  Science       Date:  1966-01-21       Impact factor: 47.728

9.  Visual memory at birth.

Authors:  A Slater; V Morison; D Rose
Journal:  Br J Psychol       Date:  1982-11

10.  Increased incidence of intraventricular hemorrhage and developmental delay in cocaine-exposed, very low birth weight infants.

Authors:  L T Singer; T S Yamashita; S Hawkins; D Cairns; J Baley; R Kliegman
Journal:  J Pediatr       Date:  1994-05       Impact factor: 4.406

View more
  16 in total

1.  Executive functioning in preschool-age children prenatally exposed to alcohol, cocaine, and marijuana.

Authors:  Julia S Noland; Lynn T Singer; Robert E Arendt; Sonia Minnes; Elizabeth J Short; Cynthia F Bearer
Journal:  Alcohol Clin Exp Res       Date:  2003-04       Impact factor: 3.455

2.  Neuroimaging of prenatal drug exposure.

Authors:  Diana L Dow-Edwards; Helene Benveniste; Marylou Behnke; Emmalee S Bandstra; Lynn T Singer; Yasmin L Hurd; L R Stanford
Journal:  Neurotoxicol Teratol       Date:  2006 May-Jun       Impact factor: 3.763

3.  ADVANCES AND REDIRECTIONS IN UNDERSTANDING EFFECTS OF FETAL DRUG EXPOSURE.

Authors:  Lynn T Singer
Journal:  J Drug Issues       Date:  1999-04-01

4.  Accuracy in Detecting Prenatal Drug Exposure.

Authors:  Robert E Arendt; Lynn T Singer; Sonia Minnes; Ann Salvator
Journal:  J Drug Issues       Date:  1999-04-01

5.  Mental health outcomes of cocaine-exposed children at 6 years of age.

Authors:  Teresa J Linares; Lynn T Singer; H Lester Kirchner; Elizabeth J Short; Meeyoung O Min; Patrick Hussey; Sonia Minnes
Journal:  J Pediatr Psychol       Date:  2005-03-31

6.  Heart rate variability by triangular index in infants exposed prenatally to cocaine.

Authors:  Sudhir Ken Mehta; Dennis M Super; Ann Salvator; Linda Goetz Fradley; David Connuck; Elizabeth S Kaufman
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-10       Impact factor: 1.468

7.  Prenatal cocaine exposure and infant cognition.

Authors:  Lynn T Singer; Laurie J Eisengart; Sonia Minnes; Julia Noland; Arthur Jey; Courtney Lane; Meeyoung O Min
Journal:  Infant Behav Dev       Date:  2005-12

8.  Inhibitory motor control at five years as a function of prenatal cocaine exposure.

Authors:  Margaret Bendersky; Giorgia Gambini; Anna Lastella; David S Bennett; Michael Lewis
Journal:  J Dev Behav Pediatr       Date:  2003-10       Impact factor: 2.225

9.  Cocaine, anemia, and neurodevelopmental outcomes in children: a longitudinal study.

Authors:  Suchitra Nelson; Edith Lerner; Robert Needlman; Ann Salvator; Lynn T Singer
Journal:  J Dev Behav Pediatr       Date:  2004-02       Impact factor: 2.225

10.  Children's cognitive ability from 4 to 9 years old as a function of prenatal cocaine exposure, environmental risk, and maternal verbal intelligence.

Authors:  David S Bennett; Margaret Bendersky; Michael Lewis
Journal:  Dev Psychol       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.